| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock | Options Exercise | $422K | +110K | +17.56% | $3.84* | 736K | Nov 1, 2022 | Direct | F1, F2, F3 |
| transaction | EVH | Class A Common Stock | Sale | -$1.1M | -38.1K | -5.17% | $28.88 | 698K | Nov 1, 2022 | Direct | F1, F2, F4 |
| transaction | EVH | Class A Common Stock | Sale | -$1.69M | -57.4K | -8.22% | $29.36 | 641K | Nov 1, 2022 | Direct | F1, F2, F5 |
| transaction | EVH | Class A Common Stock | Sale | -$417K | -13.8K | -2.15% | $30.26 | 627K | Nov 1, 2022 | Direct | F1, F2, F6 |
| transaction | EVH | Class A Common Stock | Sale | -$21.5K | -677 | -0.11% | $31.81 | 626K | Nov 1, 2022 | Direct | F1, F2 |
| holding | EVH | Class A Common Stock | 66.1K | Nov 1, 2022 | See footnote | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock Option (right to buy) | Options Exercise | $0 | -110K | -24.5% | $0.00 | 339K | Nov 1, 2022 | Class A Common Stock | 110K | $3.84 | Direct | F1, F8 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022. |
| F2 | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| F3 | Since the date of the reporting person's last ownership report, he transferred 125,955 shares of EVH Class A common stock pursuant to a domestic relations order. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.56 to $29.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.008 to $30.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.101 to $30.780, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust. |
| F8 | The Class A Common Stock Options exercised vested on December 1, 2015 and December 1, 2016. |